
A London university with major clinical research strength across several large teaching hospitals.
King's College London is one of the largest centres of health research in Europe, working across several major teaching hospitals in central and south London.
Its research strengths in neuroscience, psychiatry, and medical imaging are internationally recognised, and its clinical partnerships give it access to unusually large patient populations.
London's health technology sector benefits from the national health system as a single, very large potential customer — slow to sell into, but enormous once entered.
The university's clinical partnerships give founders access to real clinical validation environments that are otherwise difficult to obtain.
Company formation concentrates in digital health, medical imaging, neuroscience-derived therapeutics, and diagnostics.
Mental health technology is a particular strand, reflecting the university's psychiatry research base.
London hosts health-focused venture funds and a growing set of investors specialising in clinical software and diagnostics.
National innovation funding and health research grants provide substantial non-dilutive capital for clinical companies.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.png)




